Ziyuanyuan Holdings Group Ltd. has released its interim financial results for the six months ended 30 June 2025. The company reported a revenue increase of approximately 8.7%, reaching RMB203.6 million, up from RMB187.3 million in the same period of the previous year. This growth was primarily driven by a rise in income from trading medical equipment and consumables, which increased from approximately RMB160.4 million to RMB195.4 million. Profit before income tax was reported at RMB8.7 million, slightly higher than RMB8.4 million from the prior period. The company's profit and total comprehensive income for the period amounted to RMB6.7 million, compared to RMB6.2 million in the previous year. Earnings per share attributed to the owners of the company rose to 1.57 RMB cents from 1.41 RMB cents. The directors of the company have decided not to recommend the payment of an interim dividend for this period. The financial results reflect the company's ongoing efforts to navigate challenges and enhance shareholder value.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.